1. Gerin I, Ury B, Breloy I, Bouchet-Seraphin C, Noel G, Bolsee J, Halbout M, Graff J, Vertommen D, Muccioli GG, Seta N, Grahn A, Van Schaftingen E, Bommer GT (2016). ISPD produces CDP-ribitol used by FKTN and FKRP to transfer ribitol-phosphate onto a-dystroglycan. Nature communications 7(11534. doi.

2. Collard F, Baldin F, Gerin I, Bolsee J, Noel G, Graff J, Veiga-da-Cunha M, Stroobant V, Vertommen D, Houddane A, Rider MH, Linster CL, Van Schaftingen E, Bommer GT (2016). A conserved phosphatase destroys toxic glycolytic side products in mammals and yeast. Nature chemical biology 12(601-607. doi: 10.1038/nchembio.2104.

3. Arts N, Cane S, Hennequart M, Lamy J, Bommer G, Van den Eynde B, De Plaen E (2015). microRNA-155, induced by interleukin-1ss, represses the expression of microphthalmia-associated transcription factor (MITF-M) in melanoma cells. PLoS One 10(4): e0122517. doi: 10.1371/journal.pone.0122517.

4. Gerin I, Noel G, Bolsee J, Haumont O, Van Schaftingen E, Bommer GT (2014). Identification of TP53-induced glycolysis and apoptosis regulator (TIGAR) as the phosphoglycolate-independent 2,3-bisphosphoglycerate phosphatase. The Biochemical journal 458(3): 439-448. doi: 10.1042/BJ20130841.

5. Pachikian BD, Essaghir A, Demoulin JB, Catry E, Neyrinck AM, Dewulf EM, Sohet FM, Portois L, Clerbaux LA, Carpentier YA, Possemiers S, Bommer GT, Cani PD, Delzenne NM (2013). Prebiotic approach alleviates hepatic steatosis: implication of fatty acid oxidative and cholesterol synthesis pathways. Molecular nutrition & food research 57(2): 347-359. doi: 10.1002/mnfr.201200364.

6. Gauthy E, Cuende J, Stockis J, Huygens C, Lethe B, Collet JF, Bommer G, Coulie PG, Lucas S (2013). GARP is regulated by miRNAs and controls latent TGF-beta1 production by human regulatory T cells. PLoS One 8(9): e76186. doi: 10.1371/journal.pone.0076186.

7. Feng Y, Sentani K, Wiese A, Sands E, Green M, Bommer GT, Cho KR, Fearon ER (2013). Sox9 induction, ectopic Paneth cells, and mitotic spindle axis defects in mouse colon adenomatous epithelium arising from conditional biallelic Apc inactivation. Am J Pathol 183(2): 493-503. doi: 10.1016/j.ajpath.2013.04.013.

8. Linster CL, Noel G, Stroobant V, Vertommen D, Vincent MF, Bommer GT, Veiga-da-Cunha M, Van Schaftingen E (2011). Ethylmalonyl-CoA decarboxylase, a new enzyme involved in metabolite proofreading. J Biol Chem 286(50): 42992-43003. doi: 10.1074/jbc.M111.281527.

9. Feng Y, Bommer GT, Zhao J, Green M, Sands E, Zhai Y, Brown K, Burberry A, Cho KR, Fearon ER (2011). Mutant KRAS promotes hyperplasia and alters differentiation in the colon epithelium but does not expand the presumptive stem cell pool. Gastroenterology 141(3): 1003-1013 e1001-1010. doi: 10.1053/j.gastro.2011.05.007.

10. Bommer GT, MacDougald OA (2011). Regulation of lipid homeostasis by the bifunctional SREBF2-miR33a locus. Cell metabolism 13(3): 241-247. doi.

11. Bommer GT, Fearon ER (2011). Ancestries Hidden in Plain Sight - Methylation Patterns for Clonal Analysis. Gastroenterology. doi.

12. Bommer GT, Fearon ER (2011). Wnt/β-catenin Signaling in the Gastrointestinal Tract. In: Johnson LR, Wood JD, Barrett KE, Ghishan FK, Merchant JL, editors.  Physiology of the Gastrointestinal tract. Elsevier Academic Press; pp.

13. Zhai Y, Bommer GT, Feng Y, Wiese AB, Fearon ER, Cho KR (2010). Loss of estrogen receptor 1 enhances cervical cancer invasion. Am J Pathol 177(2): 884-895. doi: ajpath.2010.091166 [pii] 10.2353/ajpath.2010.091166.

14. Reka AK, Kurapati H, Narala VR, Bommer G, Chen J, Standiford TJ, Keshamouni VG (2010). Peroxisome proliferator-activated receptor-{gamma} activation inhibits tumor metastasis by antagonizing Smad3-mediated epithelial-mesenchymal transition. Mol Cancer Ther 9(12): 3221-3232. doi: 9/12/3221 [pii] 10.1158/1535-7163.MCT-10-0570.

15. Gerin I, Clerbaux LA, Haumont O, Lanthier N, Das AK, Burant CF, Leclercq IA, MacDougald OA, Bommer GT (2010). Expression of miR-33 from an SREBP2 intron inhibits cholesterol export and fatty acid oxidation. J Biol Chem 285(44): 33652-33661. doi: M110.152090 [pii] 10.1074/jbc.M110.152090.

16. Gerin I, Bommer GT, McCoin CS, Sousa KM, Krishnan V, MacDougald OA (2010). Roles for miRNA-378/378* in adipocyte gene expression and lipogenesis. Am J Physiol Endocrinol Metab 299(2): E198-206. doi: ajpendo.00179.2010 [pii] 10.1152/ajpendo.00179.2010.

17. Bommer GT, Feng Y, Iura A, Giordano TJ, Kuick R, Kadikoy H, Sikorski D, Wu R, Cho KR, Fearon ER (2010). IRS1 regulation by Wnt/beta-catenin signaling and varied contribution of IRS1 to the neoplastic phenotype. J Biol Chem 285(3): 1928-1938. doi: M109.060319 [pii] 10.1074/jbc.M109.060319.

18. Rowe RG, Li XY, Hu Y, Saunders TL, Virtanen I, Garcia de Herreros A, Becker KF, Ingvarsen S, Engelholm LH, Bommer GT, Fearon ER, Weiss SJ (2009). Mesenchymal cells reactivate Snail1 expression to drive three-dimensional invasion programs. J Cell Biol 184(3): 399-408. doi: jcb.200810113 [pii] 10.1083/jcb.200810113.

19. Ji Q, Hao X, Zhang M, Tang W, Yang M, Li L, Xiang D, Desano JT, Bommer GT, Fan D, Fearon ER, Lawrence TS, Xu L (2009). MicroRNA miR-34 inhibits human pancreatic cancer tumor-initiating cells. PLoS One 4(8): e6816. doi: 10.1371/journal.pone.0006816.

20. Herbst A, Bommer GT, Kriegl L, Jung A, Behrens A, Csanadi E, Gerhard M, Bolz C, Riesenberg R, Zimmermann W, Dietmaier W, Wolf I, Brabletz T, Goke B, Kolligs FT (2009). ITF-2 is disrupted via allelic loss of chromosome 18q21, and ITF-2B expression is lost at the adenoma-carcinoma transition. Gastroenterology 137(2): 639-648, 648 e631-639. doi: S0016-5085(09)00606-4 [pii] 10.1053/j.gastro.2009.04.049.

21. Gerin I, Bommer GT, Lidell ME, Cederberg A, Enerback S, Macdougald OA (2009). On the role of FOX transcription factors in adipocyte differentiation and insulin-stimulated glucose uptake. J Biol Chem 284(16): 10755-10763. doi: M809115200 [pii] 10.1074/jbc.M809115200.

22. Fearon ER, Bommer GT (2008). Progressing from Gene Mutations to Cancer. In: Abeloff MD, Armitage JO, Niederhuber JE, Kastan MB, McKenna WG, editors.  Abeloff's Clinical Oncology. Churchill Livingstone Elsevier, Philadelphia pp 207-222.

23. Fearon ER, Bommer GT (2008). Molecular biology of colorectal cancer. In: DeVita VTJ, Lawrence TS, Rosenberg SA, editors.  Cancer: Principles & Practise of Oncology. Lippincott Williams & Wilkins, Philadelphia; pp.

24. Bommer GT, Fearon ER (2008). Molecular Alterations in colorectal cancer. In: Mendelsohn J, Howley PM, Israel MA, Gray JW, Thompson CB, editors.  Molecular Basis of Cancer. Saunders, Philadelphia; pp 289-312.

25. Akyol A, Hinoi T, Feng Y, Bommer GT, Glaser TM, Fearon ER (2008). Generating somatic mosaicism with a Cre recombinase-microsatellite sequence transgene. Nat Methods 5(3): 231-233. doi: nmeth.1182 [pii] 10.1038/nmeth.1182.

26. Feng Y, Bommer GT, Zhai Y, Akyol A, Hinoi T, Winer I, Lin HV, Cadigan KM, Cho KR, Fearon ER (2007). Drosophila split ends homologue SHARP functions as a positive regulator of Wnt/beta-catenin/T-cell factor signaling in neoplastic transformation. Cancer Res 67(2): 482-491. doi: 67/2/482 [pii] 10.1158/0008-5472.CAN-06-2314.

27. Bommer GT, Gerin I, Feng Y, Kaczorowski AJ, Kuick R, Love RE, Zhai Y, Giordano TJ, Qin ZS, Moore BB, MacDougald OA, Cho KR, Fearon ER (2007). p53-mediated activation of miRNA34 candidate tumor-suppressor genes. Curr Biol 17(15): 1298-1307. doi: S0960-9822(07)01638-7 [pii] 10.1016/j.cub.2007.06.068.

28. Bommer GT, Fearon ER (2007). Role of c-Myc in Apc mutant intestinal phenotype: case closed or time for a new beginning? Cancer Cell 11(5): 391-394. doi: S1535-6108(07)00121-3 [pii] 10.1016/j.ccr.2007.04.015.

29. Winer IS, Bommer GT, Gonik N, Fearon ER (2006). Lysine residues Lys-19 and Lys-49 of beta-catenin regulate its levels and function in T cell factor transcriptional activation and neoplastic transformation. J Biol Chem 281(36): 26181-26187. doi: M604217200 [pii] 10.1074/jbc.M604217200.

30. Lenhard K, Bommer GT, Asutay S, Schauer R, Brabletz T, Goke B, Lamerz R, Kolligs FT (2005). Analysis of promoter methylation in stool: a novel method for the detection of colorectal cancer. Clin Gastroenterol Hepatol 3(2): 142-149. doi: S154235650400624X [pii].

31. Bommer GT, Jager C, Durr EM, Baehs S, Eichhorst ST, Brabletz T, Hu G, Frohlich T, Arnold G, Kress DC, Goke B, Fearon ER, Kolligs FT (2005). DRO1, a gene down-regulated by oncogenes, mediates growth inhibition in colon and pancreatic cancer cells. J Biol Chem 280(9): 7962-7975. doi: M412593200 [pii] 10.1074/jbc.M412593200.